Markers of insulin signaling such as Ir and Irs-2, shown to be altered in livers of humans and rodents of NAFLD [40,41], were also significantly lower in the livers of FFC-fed mice when compared to FFC + S–fed animals. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.